Literature DB >> 10708552

Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA.

A P Goldstone1, I Morgan, J G Mercer, D G Morgan, K M Moar, M A Ghatei, S R Bloom.   

Abstract

Leptin, the adipocyte-derived plasma hormone, and CNS GLP-1 neurons reduce food intake and body weight. GLP-1 is produced in the CNS by post-translational processing of pre-proglucagon. ICV leptin administration prevented the reduction in hypothalamic GLP-1 peptide content seen in pair-fed food-restricted rats (P < 0.05). There was a significant overall positive correlation between pre-proglucagon mRNA expression in the NTS and hypothalamic GLP-1 peptide content (r = +0.34, P < 0.05). Intraperitoneal leptin administration also increased hypothalamic GLP-1 peptide in food-restricted mice (P < 0. 05). This supports the hypothesis that the anorectic actions of leptin are in part due to stimulation of GLP-1 neurons. Reduced CNS GLP-1 neuronal activity during food deprivation may act to stimulate feeding behaviour, and perhaps also inhibit hypothalamic LHRH neurons, as part of the neuroendocrine response to starvation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708552     DOI: 10.1006/bbrc.2000.2288

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Direct regulation of the proglucagon gene by insulin, leptin, and cAMP in embryonic versus adult hypothalamic neurons.

Authors:  Prasad S Dalvi; Frederick D Erbiceanu; David M Irwin; Denise D Belsham
Journal:  Mol Endocrinol       Date:  2012-06-05

2.  Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

Authors:  Claude Knauf; Patrice D Cani; Christophe Perrin; Miguel A Iglesias; Jean François Maury; Elodie Bernard; Fadilha Benhamed; Thierry Grémeaux; Daniel J Drucker; C Ronald Kahn; Jean Girard; Jean François Tanti; Nathalie M Delzenne; Catherine Postic; Rémy Burcelin
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Divergent leptin signaling in proglucagon neurons of the nucleus of the solitary tract in mice and rats.

Authors:  Lihong Huo; Kevin M Gamber; Harvey J Grill; Christian Bjørbaek
Journal:  Endocrinology       Date:  2007-11-01       Impact factor: 4.736

Review 4.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

Review 5.  PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.

Authors:  Stefan Trapp; Simon C Cork
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

Review 6.  GLP-1 and energy balance: an integrated model of short-term and long-term control.

Authors:  Jason G Barrera; Darleen A Sandoval; David A D'Alessio; Randy J Seeley
Journal:  Nat Rev Endocrinol       Date:  2011-06-07       Impact factor: 43.330

Review 7.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

8.  Leptin directly depolarizes preproglucagon neurons in the nucleus tractus solitarius: electrical properties of glucagon-like Peptide 1 neurons.

Authors:  Kazunari Hisadome; Frank Reimann; Fiona M Gribble; Stefan Trapp
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

Review 9.  Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis.

Authors:  Diana L Williams
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

10.  Differential secretion of satiety hormones with progression of obesity in JCR:LA-corpulent rats.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Obesity (Silver Spring)       Date:  2008-01-24       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.